Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.
Lazrek Y, Dubreuil O, Garambois V, Gaborit N, Larbouret C, Le Clorennec C, Thomas G, Leconet W, Jarlier M, Pugnière M, Vié N, Robert B, Monnet C, Bouayadi K, Kharrat H, Mondon P, Pèlegrin A, Chardès T.
Lazrek Y, et al. Among authors: le clorennec c.
Neoplasia. 2013 Mar;15(3):335-47. doi: 10.1593/neo.121960.
Neoplasia. 2013.
PMID: 23479511
Free PMC article.